Aewajin Spicule Shots 300 Liquid
NDC Package 73466-0010-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Aewajin Spicule Shots 300 (niacinamide, adenosine) liquids is take a suitable amount on the skin. This formulation utilizes a liquid delivery system. Marketed by Misocos, this product is identified by NDC 73466-0010.

Identification & Billing

NDC Package Code
73466-0010-1
Package Description
30 mL in 1 BOTTLE, DROPPER
Product Code
11-Digit Billing Format
73466001001

Clinical Specifications

Proprietary Name
Aewajin Spicule Shots 300
Non-Proprietary Name
Niacinamide, Adenosine
Substance Name
Adenosine; Niacinamide
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Usage Information
Take a suitable amount on the skin

Regulatory & Marketing

Labeler Name
Misocos
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
05-01-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73466-0010-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Aewajin Spicule Shots 300, a human over the counter drug labeled by Misocos. This liquid is formulated for topical use and contains adenosine; niacinamide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Misocos on May 01, 2025. The current certification is valid through December 31, 2026.

How is this Misocos product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73466001001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
73466-0010-1
11-Digit CMS (5-4-2)
73466-0010-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.